EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery

Paula Urones, Paula Juiz-Valiña, Elena Outeiriño-Blanco, María Jesús García-Brao, Vanesa Balboa-Barreiro, Fernando Cordido, Susana Sangiao-Alvarellos iD

Journal of Endocrinology · 01.07.2025 · 266 (1)

DOI: 10.1530/joe-25-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 18.06.2025. Verfasst von Paula Urones und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Bariatric Surgery, Obesity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bariatric surgery (BS) is the most effective long-term approach for weight loss and improvement of obesity-related comorbidities. Growth differentiation factor 15 (GDF15), a cytokine that enhances insulin sensitivity and reduces food intake, is a promising therapeutic target for obesity. This study assessed changes in circulating GDF15 levels in obesity and following BS, examining their associations with anthropometric, clinical, and biochemical parameters. Circulating GDF15 levels were measured in normal-weight individuals and patients with obesity before BS and at 3, 6 and 12 months post-surgery. Correlation analyses and linear mixed models were used to investigate variations in circulating GDF15 levels and to identify variables associated with GDF15 concentration. Circulating GDF15 levels were elevated in patients with obesity compared to normal-weight individuals and were higher in men than in women. In the combined cohort of obese and normal-weight individuals, circulating GDF15 levels positively correlated with weight, BMI, fat mass, glucose markers, C-reactive protein, transaminases, triglycerides, urea, creatinine and uric acid, and negatively correlated with apolipoprotein A and total, HDL and LDL cholesterol. In the obese cohort, however, circulating GDF15 levels showed a negative correlation with fat mass, while other associations persisted. After BS, circulating GDF15 levels significantly decreased, particularly in patients with hypertension or type 2 diabetes (T2D). One year post-surgery, ΔGDF15 was negatively associated with BMI and positively with excess weight loss and excess BMI loss. In conclusion, BS significantly reduces circulating GDF15 levels, particularly in patients with hypertension or T2D, indicating an association with clinical improvement after BS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Bariatric SurgeryObesityHumansMaleFemaleBiomarkersAdultMiddle AgedTreatment OutcomeWeight LossBody Mass Index

Stichwörter der Autor:innen

GDF15bariatric surgerydiabeteshypertension

Substanzen

Growth Differentiation Factor 15BiomarkersGDF15 protein, human

Autor:innen und Institutionen

ORCID-Profile: Susana Sangiao-Alvarellos

Zitieren

APA

Urones, P., Juiz-Valiña, P., Outeiriño-Blanco, E., García-Brao, M. J., Balboa-Barreiro, V., Cordido, F., & Sangiao-Alvarellos, S. (2025). Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery. Journal of Endocrinology, 266(1). https://doi.org/10.1530/joe-25-0010

Vancouver

Urones P, Juiz-Valiña P, Outeiriño-Blanco E, García-Brao MJ, Balboa-Barreiro V, Cordido F, et al. Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery. Journal of Endocrinology. 2025;266(1). doi:10.1530/joe-25-0010

BibTeX
@article{Urones2025,
  author = {Urones, Paula and Juiz-Valiña, Paula and Outeiriño-Blanco, Elena and García-Brao, María Jesús and Balboa-Barreiro, Vanesa and Cordido, Fernando and Sangiao-Alvarellos, Susana},
  title = {Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery},
  journal = {Journal of Endocrinology},
  year = {2025},
  volume = {266},
  number = {1},
  doi = {10.1530/joe-25-0010}
}
Kostenlos starten →